TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
61.70
+1.17 (1.93%)
At close: Dec 20, 2024, 4:00 PM
62.00
+0.30 (0.49%)
After-hours: Dec 20, 2024, 7:55 PM EST
TransMedics Group Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 116.1, with a low estimate of 75 and a high estimate of 178. The average target predicts an increase of 88.17% from the current stock price of 61.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TMDX stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 6 | 6 | 5 | 4 |
| Hold | 2 | 2 | 2 | 2 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades $116 → $75 | Buy → Hold | Downgrades | $116 → $75 | +21.56% | Dec 17, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $110 → $90 | Buy | Maintains | $110 → $90 | +45.87% | Dec 11, 2024 |
| Baird | Baird | Buy Maintains $150 → $120 | Buy | Maintains | $150 → $120 | +94.49% | Dec 11, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $125 | Buy | Maintains | $125 | +102.59% | Dec 3, 2024 |
Financial Forecast
Revenue This Year
438.91M
from 241.62M
Increased by 81.65%
Revenue Next Year
542.48M
from 438.91M
Increased by 23.60%
EPS This Year
0.99
from -0.77
EPS Next Year
1.48
from 0.99
Increased by 49.28%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 458.3M | 603.0M | 708.6M | |||
| Avg | 438.9M | 542.5M | 652.9M | |||
| Low | 416.4M | 498.5M | 594.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 89.7% | 37.4% | 30.6% | |||
| Avg | 81.7% | 23.6% | 20.4% | |||
| Low | 72.3% | 13.6% | 9.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.12 | 1.79 | 2.89 |
| Avg | 0.99 | 1.48 | 2.36 |
| Low | 0.81 | 1.12 | 1.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 80.0% | 95.1% |
| Avg | - | 49.3% | 59.6% |
| Low | - | 12.7% | 19.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.